USFDA pulls up Mylan for manufacturing violations at Andhra plant

USFDA pulls up Mylan for manufacturing violations at Andhra plant In a warning letter issued to the company#39;s CEO Heather Bresch, the US Food and Drug Administration (USFDA) said inspectors during May 27 to June 5, this year found significant deviations from standard manufacturing practices at the company#39;s Unit 8 in G Chodavaram village in Vizianagaram.

No comments:

Post a Comment